Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2013-03-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-013-2111-3PMID 23475103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy

  2009cited by this paper
• Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors

  2006cited by this paper
• Dexamethasone protects against cisplatin-induced activation of the mitochondrial apoptotic pathway in human osteosarcoma cells

  2006cited by this paper
• Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.

  2006cited by this paper
• Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction.

  2006cited by this paper
• Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa.

  2006cited by this paper
• Glucocorticoid Receptor-induced MAPK Phosphatase-1 (MPK-1) Expression Inhibits Paclitaxel-associated MAPK Activation and Contributes to Breast Cancer Cell Survival*

  2005cited by this paper
• Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.

  2005cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Pretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts

  2004cited by this paper
• Cytokines in cancer pathogenesis and cancer therapy

  2004cited by this paper
• Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine

  2004cited by this paper
• High interstitial fluid pressure — an obstacle in cancer therapy

  2004cited by this paper
• The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer

  2004cited by this paper
• Hematopoietic Protection by Dexamethasone or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients Treated With Carboplatin and Ifosfamide

  2003cited by this paper
• Dexamethasone inhibits TNF‐α‐induced apoptosis and IAP protein downregulation in MCF‐7 cells

  2001cited by this paper
• Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells.

  2001cited by this paper
• Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Biological implications of macrophage infiltration in human tumor angiogenesis

  1999cited by this paper
• Reduction in Carboplatin Hematopoietic Toxicity in Tumor Bearing Mice: Comparative Mechanisms and Effects of Interleukin-1β and Corticosteroids

  1997cited by this paper
• Delivery of Molecular Medicine to Solid Tumors

  1996cited by this paper
• Corticosteroid alteration of carboplatin-induced hematopoietic toxicity in a murine model.

  1995cited by this paper
• Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.

  1993cited by this paper
• Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

  1990cited by this paper
• Transport of molecules in the tumor interstitium: a review.

  1987cited by this paper
• Corticosteroid effect on granulopoiesis in mice after cyclophosphamide.

  1977cited by this paper
• Toward Cancer Therapy in Carcinomas Glucocorticoid Cotreatment Induces Apoptosis Resistance Updated Version Cited Articles Citing Articles E-mail Alerts Glucocorticoid Cotreatment Induces Apoptosis Resistance toward Cancer Therapy in Carcinomas 1

  year unknowncited by this paper

• In Vivo Calcium Imaging in the Near-Infrared II Window

  2025cites this paper
• Dexamethasone induces cancer mitigation and irreversible senescence in lung cancer cells via damaging cortical actin and sustained hyperphosphorylation of pRb.

  2023cites this paper
• The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

  2023cites this paper
• Advantages and drawbacks of dexamethasone in glioblastoma multiforme.

  2022cites this paper
• Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer

  2021cites this paper
• The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score.

  2020cites this paper
• The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review.

  2018cites this paper
• Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies

  2018cites this paper
• Glucocorticoids as an adjunct to oncologic treatment in solid malignancies - Not an innocent bystander.

  2018cites this paper
• Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis

  2017cites this paper
• Dexamethasone induced apoptosis of A549 cells via the TGF-β1/Smad2 pathway

  2017cites this paper
• Glucocorticoid receptors in lung cancer: new perspectives.

  2016cites this paper
• Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis

  2016cites this paper
• Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61

  2015cites this paper
• Responses to Overdiagnosis in Thyroid Cancer Screening among Korean Women

  2015cites this paper
• The Critical Role of Mechanism-Based Models for Understanding and Predicting Liposomal Drug Loading, Binding and Release Kinetics

  2013cites this paper